Table 1.
Characteristics of patients.
| Sex (M:F) | 14:6 |
| Age | 51.2 ± 14.4 (range: 21–76) years |
| Diagnosis | |
| Pheochromocytoma:paraganglioma | 13:7 |
| Complications | 18 (90.0%) |
| Hypertension | 11 (55.0%) |
| Tachycardia | 1 (5.0%) |
| Arrhythmia | 2 (10.0%) |
| Orthostatic hypotension | 1 (5.0%) |
| Headache | 3 (15.0%) |
| Palpitation | 1 (5.0%) |
| Cold sense | 1 (5.0%) |
| Constipation | 4 (20.0%) |
| Symptom | |
| Headache | 2 (10.0%) |
| Epigastric pain | 1 (5%) |
| Anginal pain | 1 (5%) |
| Palpitation | 2 (10.0%) |
| Frigidity | 2 (10.0%) |
| Nausea and vomiting | 5 (25.0%) |
| Constipation | 5 (25.0%) |
| Laboratory examinations (range, outside of normal range (%)) | |
| White blood cell (*103/mm3) | 5.5 ± 1.6 (range: 3.0–9.6, 10.0%) |
| Platelets (**104/mm3) | 20.3 ± 6.7 (range: 12.9–38.5, 20.0%) |
| Hemoglobin (g/dL) | 13.4 ± 1.5 (range: 11.0–16.6, 30.0%) |
| eGFR (mL/min/1.73 m2) | 76.4 ± 21.3 (range: 46.4–131.87, 30.0%) |
| HbA1c (%) | 5.7 ± 0.7 (range: 5.1–7.8, 15.0%) |
| BNP (pg/mL) | 21.6 ± 35.8 (range: 4.0–165.9, 35.0%) |
| Plasma adrenaline (ng/mL) | 1.5 ± 3.3 (range: 0.005–12.0, 25.0%) |
| Plasma noradrenaline (ng/mL) | 76.4 ± 168.1 (range: 0.1–563.0, 55.0%) |
| Plasma dopamine (ng/mL) | 2.0 ± 4.4 (range: 0.005–14.0, 35.0%) |
| Urinary adrenaline (μg/day) | 16.3 ± 36.8 (range: 0.5–163.2, 15.0%) |
| Urinary noradrenaline (μg/day) | 545.3 ± 1162.6(range: 87.6–5310.0, 75.0%) |
| Urinary dopamine (μg/day) | 1311.5 ± 936.7(range: 460.0–4000.0, 45.0%) |
| Urinary metanephrine (mg/day) | 0.4 ± 1.0 (range: 0.01–4.62, 35.0%) |
| Urinary normetanephrine (mg/day) | 6.8 ± 14.6 (range: 0.15–52.0, 80.0%) |
| Urinary vanilylmandelic acid (mg/day) | 16.0 ± 31.3 (range: 3.1–139.0, 55.0%) |
| Urinary homovanillic acid (mg/day) | 4.5 ± 1.4 (range: 2.7–9.5, 10.0%) |
eGFR: estimated glomerular filtration rate; HbA1c: hemoglobin A1c; BNP: brain natriuretic peptide.